Better Therapeutics Inc
General ticker "BTTX" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $8.7M
Better Therapeutics Inc does not follow the US Stock Market performance with the rate: -27.5%.
Estimated limits based on current volatility of 16.9%: low 0.01$, high 0.01$
Factors to consider:
- Current price 98.5% below predicted low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 predicted range: [0.86$, 2.90$]
- 2023-12-31 to 2024-12-30 predicted range: [0.60$, 2.22$]
Short-term BTTX quotes
Long-term BTTX plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.00MM | $0.00MM |
| Operating Expenses | $6.33MM | $30.56MM | $38.26MM |
| Operating Income | $-6.32MM | $-30.56MM | $-38.26MM |
| Non-Operating Income | $0.09MM | $-9.93MM | $-1.49MM |
| Interest Expense | $0.10MM | $0.18MM | $1.49MM |
| R&D Expense | $2.98MM | $19.44MM | $16.44MM |
| Income(Loss) | $-6.23MM | $-40.49MM | $-39.75MM |
| Taxes | $0.15MM | $-0.15MM | $0.01MM |
| Profit(Loss) | $-6.39MM | $-40.34MM | $-39.76MM |
| Stockholders Equity | $-6.76MM | $36.72MM | $-0.90MM |
| Assets | $6.39MM | $50.96MM | $22.94MM |
| Operating Cash Flow | $-5.77MM | $-30.82MM | $-28.93MM |
| Investing Cash Flow | $-2.31MM | $-1.07MM | $-1.18MM |
| Financing Cash Flow | $7.45MM | $72.33MM | $5.28MM |
| Earnings Per Share* | $-0.85 | $-1.71 | $-1.69 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.